Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 25,000 shares at $61.61 ($1.5M) on 2019-12-18, disclosed to the SEC on 2019-12-20.
Open-market sale of $1.5M EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.61 | 9,973 | $614K | 39.7% |
| 2 | $61.61 | 9,973 | $614K | 39.7% |
| 3 | $62.49 | 825 | $52K | 3.3% |
| 4 | $62.49 | 825 | $52K | 3.3% |
| 5 | $63.31 | 1,702 | $108K | 7.0% |
| 6 | $63.31 | 1,702 |
| $108K |
| 7.0% |
| Total | $61.90 avg | 25,000 | $1.5M | 100% |
| Filing → |
| EIDX | SELL | 2020-10-30 | $456K | — | Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-09-27 | $96K | — | Filing → |